From AIDS Research and Human Retroviruses, by Veronese, Turpin and Feuer A workshop entitled Beyond 2010: Gaps, Challenges, and Priorities for the Future of Preclinical HIV Pre-Exposure Prophylaxis (PrEP) was sponsored by the Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), on October 20-21, 2009, in Read More >>

via IRMA Enhance your advocacy skills and bone up on some of the basics. Dr. Jim Turpin of the Microbicide Research Branch at the National Institutes of Health, National Institutes of Allergy and Infectious Diseases, will explain the basic science of drug discovery – the research that happens before we move on to Phase I safety testing Read More >>

Each step is part of the waft and weave leading to a safe, acceptable and effective rectal microbicide. IRMA asks Jim Turpin, Ph.D., Microbicide Research Branch*, about the National Institutes of Health and its commitment to rectal microbicides IRMA: Why are rectal microbicides an important part of the NIAID/NIH prevention portfolio? Dr. Turpin: Rectal microbicides are important Read More >>